tiprankstipranks
Trending News
More News >
FORESIGHT AUTONOMOUS HOLDINGS LTD. (IL:FRSX)
:FRSX
Israel Market

Foresight (FRSX) AI Stock Analysis

Compare
2 Followers

Top Page

IL

Foresight

(FRSX)

Rating:38Underperform
Price Target:
6.00
▼(-35.48%Downside)
Foresight's overall stock score is severely impacted by its poor financial performance, characterized by ongoing losses, declining revenue, and negative cash flow. Technical analysis indicates weak market momentum with the stock being oversold, while valuation metrics highlight unattractive investment prospects. The lack of positive earnings call data or notable corporate events further diminishes its investment appeal.

Foresight (FRSX) vs. iShares MSCI Israel ETF (EIS)

Foresight Business Overview & Revenue Model

Company DescriptionForesight Autonomous Holdings Ltd. (FRSX) is a leading technology company specializing in the development and commercialization of sensor systems for advanced driver assistance systems (ADAS) and autonomous vehicles. Operating primarily within the automotive and technological innovation sectors, Foresight offers cutting-edge stereo vision solutions designed to enhance vehicle safety and performance. Their core products include QuadSight, a multi-spectral vision system designed for all-weather and lighting conditions, and Eye-Net Protect, a cellular-based V2X (vehicle-to-everything) accident prevention solution.
How the Company Makes MoneyForesight generates revenue through the sale and licensing of its proprietary vision systems and software solutions. The company monetizes its technology by partnering with automotive manufacturers and suppliers who integrate Foresight's systems into their vehicles, thus enhancing their ADAS and autonomous driving capabilities. Key revenue streams include direct product sales, licensing fees, and long-term contracts with automotive industry players. Additionally, Foresight may engage in joint ventures and strategic partnerships to expand its market reach and drive technological innovation, contributing further to its earnings.

Foresight Financial Statement Overview

Summary
Foresight is experiencing ongoing financial challenges with a negative net income and declining revenue. The negative EBIT and EBITDA margins highlight severe profitability issues, and cash flow pressures exacerbate these concerns despite manageable debt levels.
Income Statement
25
Negative
Foresight continues to face significant challenges on the income statement front, highlighted by negative net income and declining revenue. The gross profit margin for 2024 is approximately 60.55%, but the company experienced a revenue decline of 12.25% compared to the previous year. The EBIT and EBITDA margins are both negative, reflecting ongoing losses, which is a major concern for profitability and sustainability.
Balance Sheet
40
Negative
The balance sheet shows a weakening position with decreasing total assets and stockholders' equity. The debt-to-equity ratio stands at approximately 0.26, indicating manageable leverage. However, the return on equity is negative due to persistent losses. The equity ratio remains relatively stable, suggesting some degree of financial stability despite ongoing challenges.
Cash Flow
30
Negative
Cash flow analysis reveals a negative free cash flow, although there is a slight improvement in operating cash flow relative to net income. The company continues to rely on financing activities to support cash flow needs. The free cash flow to net income ratio is negative, indicating cash flow pressures.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue436.00K497.00K550.00K120.00K0.00
Gross Profit264.00K354.00K298.00K53.00K0.00
EBITDA-12.48M-16.03M-17.24M-15.79M-12.58M
Net Income-11.14M-18.41M-21.68M-15.04M-15.14M
Balance Sheet
Total Assets9.74M19.31M32.89M53.48M49.97M
Cash, Cash Equivalents and Short-Term Investments7.15M16.11M26.39M45.60M43.98M
Total Debt1.56M1.63M2.00M2.73M1.28M
Total Liabilities3.02M3.31M4.11M4.85M2.88M
Stockholders Equity6.07M15.39M28.33M48.41M47.02M
Cash Flow
Free Cash Flow-11.12M-15.05M-17.37M-12.36M-11.54M
Operating Cash Flow-11.05M-14.93M-17.06M-12.13M-11.49M
Investing Cash Flow1.78M7.09M8.98M-12.58M85.00K
Financing Cash Flow903.00K4.18M0.0014.16M45.28M

Foresight Technical Analysis

Technical Analysis Sentiment
Negative
Last Price9.30
Price Trends
50DMA
7.50
Negative
100DMA
8.74
Negative
200DMA
10.23
Negative
Market Momentum
MACD
-0.38
Negative
RSI
41.73
Neutral
STOCH
53.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:FRSX, the sentiment is Negative. The current price of 9.3 is above the 20-day moving average (MA) of 6.58, above the 50-day MA of 7.50, and below the 200-day MA of 10.23, indicating a bearish trend. The MACD of -0.38 indicates Negative momentum. The RSI at 41.73 is Neutral, neither overbought nor oversold. The STOCH value of 53.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:FRSX.

Foresight Risk Analysis

Foresight disclosed 42 risk factors in its most recent earnings report. Foresight reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Foresight Peers Comparison

Overall Rating
UnderperformOutperform
Sector (69)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
¥229.55B14.487.64%2.71%9.13%8.50%
ILRZR
47
Neutral
190.82M
225.62%15.64%
42
Neutral
36.94M
-35.05%36.67%
38
Underperform
44.43M
-13.19%57.47%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:FRSX
Foresight
6.20
-6.70
-51.94%
IL:NRGN
Nrgene
255.40
-114.00
-30.86%
IL:RZR
Razor Labs
484.80
22.40
4.84%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 24, 2025